Announcements Trials
Browse Landscape

Phase

Phase 2 22Phase NA 19Phase 1 15Phase 1/2 14Phase EARLY_PHASE1 5Phase 3 4Phase 2/3 4Phase 4 1

Status

Completed 201Unknown 134Recruiting 48Not yet recruiting 30Terminated 29Withdrawn 16Active not recruiting 10Enrolling by invitation 3Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3Genitourinary 1Gastrointestinal 1

Conditions

Stomach Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Surgical Procedures, Operative 1Oxaliplatin 1Leucovorin 1Irinotecan 1Fluorouracil 1Congresses as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Suspended × Gastrointestinal × Clear all
NCT02366819 2026-03-30

Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

University of Chicago

Phase 4 Suspended
36 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡